Publication Name	World Journal of Methodology
Manuscript ID	17403
Country	Türkiye

Received	2015-03-05 08:33
Peer-Review Started	2015-03-05 16:56
To Make the First Decision	2015-04-10 17:23
Return for Revision	2015-04-15 11:40
Revised	2015-04-28 21:52
Second Decision	2015-05-07 09:56
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-05-18 17:05
Articles in Press	2015-05-18 17:05
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-06-11 16:46
Publish the Manuscript Online	2015-07-07 20:52

ISSN	2222-0682 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Current Helicobacter pylori treatment in 2014
Manuscript Source	Invited Manuscript
All Author List	Fatih Ermis and Elif Senocak Tasci
Funding Agency and Grant Number
Corresponding Author	Fatih Ermis, MD, Associate Professor, Department of Gastroenterology, Duzce University Faculty of Medicine, Beciyorukler Street, Konuralp, 81620 Duzce, Turkey. fatihermis2@hotmail.com
Key Words	Helicobacter pylori; Eradication; Treatment; Bismuth-quadruple therapy; Sequential therapy; Con­comitant therapy; Hybrid therapy
Core Tip	In this review, we focused on different treatment regimens used for Helicobacter pylori eradication. The worldwide increase in antibiotic resistance, especially clarithromycin, caused change in the preferred initial treatments. The efficiency of bismuth-quadruple therapy, sequential, concomitant and hybrid therapies are emphasized in relation to each other. In addition, adjuvant therapies to increase the efficiency are reviewed. In conclusion, the optimal approach for eradication was found to be the individualized therapy.
Publish Date	2015-07-07 20:52
Citation	Ermis F, Senocak Tasci E. Current Helicobacter pylori treatment in 2014. World J Methodol 2015; 5(2): 101-107
URL	http://www.wjgnet.com/2222-0682/full/v5/i2/101.htm
DOI	http://dx.doi.org/10.5662/wjm.v5.i2.101

Full Article (PDF)	WJM-5-101.pdf
Full Article (Word)	WJM-5-101.doc
Manuscript File	17403-Review.docx
Answering Reviewers	17403-Answering reviewers.pdf
Audio Core Tip	17403-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	17403-Conflict-of-interest statement.pdf
Copyright License Agreement	17403-Copyright assignment.pdf
Peer-review Report	17403-Peer-review(s).pdf
Scientific Misconduct Check	17403-Scientific misconduct check.pdf
Scientific Editor Work List	17403-Scientific editor work list.pdf